MD Anderson Cancer Center Archives - Page 2 of 2

Senate Confirms Stephen Hahn as Next FDA Commissioner

Commissioner, FDA, FDA/Regulatory, Generics, MD Anderson Cancer Center, Oncologists, Senate, U.S. Opioid Crisis, Vaping

The U.S. Senate confirmed Stephen Hahn as commissioner of the U.S. Food and Drug Administration in a 72-18 vote.

December 13, 2019/by BioSpace

Inside drugmakers’ strategy to boost cancer medicines with ‘Lazarus effect’

Cancer, Centers, Gene Testing, Genes, Genetic Sequencing, Genetics, Genomics, Insurers, MD Anderson Cancer Center, Oncologists, Oncology

In the halls of MD Anderson Cancer Center, Vitrakvi is known for having a “Lazarus effect” in some patients because the drug can reverse late-stage cancer that has defied all other treatment options.

September 6, 2019/by Reuters Health